Thromboxane A(2) is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis

Citation
To. Daniel et al., Thromboxane A(2) is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis, CANCER RES, 59(18), 1999, pp. 4574-4577
Citations number
25
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
18
Year of publication
1999
Pages
4574 - 4577
Database
ISI
SICI code
0008-5472(19990915)59:18<4574:TAIAMO>2.0.ZU;2-5
Abstract
Cyclooxygenase-2 (COX-2) inhibitors reduce angiogenic responses to a variet y of stimuli, suggesting that products of COX-2 may mediate critical steps. Here, we show that thromboxane A, TXA(2) is one of several eicosanoid prod ucts generated by activated human microvascular endothelial cells. Selectiv e COX-2 antagonists inhibit TXA(2) production, endothelial migration, and f ibroblast growth factor-induced corneal angiogenesis, Endothelial migration and corneal angiogenesis are similarly inhibited by a TXA(2) receptor anta gonist, SQ29548, A TXA(2) agonist, U46619, reconstitutes both migration and angiogenesis responses under COX-2-inhibited conditions, These findings id entify TXA(2) as a COX-2 product that functions as a critical intermediary of angiogenesis.